SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-039601
Filing Date
2018-06-27
Accepted
2018-06-27 14:26:28
Documents
2
Period of Report
2018-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7025
2 EX-24 DOCUMENT attachment1.htm EX-24 3532
  Complete submission text file 0001209191-18-039601.txt   11919
Mailing Address 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025 (650) 352-4150
Forty Seven, Inc. (Issuer) CIK: 0001667633 (see all company filings)

IRS No.: 474065674 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O FORTY SEVEN, INC. 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
Takimoto Chris H (Reporting) CIK: 0001743780 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38554 | Film No.: 18921446